Brochure More information from http://www.researchandmarkets.com/reports/3618524/ Portal Hypertension Global Clinical Trials Review, H1, 2016 Description: Portal Hypertension Global Clinical Trials Review, H1, 2016 Summary Our clinical trial report, Portal Hypertension Global Clinical Trials Review, H1, 2016" provides an overview of Portal Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Portal Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma etrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Contents: List of Tables List of Figures Report Guidance
Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Trials in Asia-Pacific Top Five Countries Contributing to Clinical Trials in Europe Top Countries Contributing to Clinical Trials in North America Top Countries Contributing to Clinical Trials in Middle East and Africa Top Countries Contributing to Clinical Trials in Central and South America Clinical Trials by G7 Countries: Proportion of Portal Hypertension to Cardiovascular Clinical Trials Clinical Trials by Phase in G7 Countries Clinical Trials in G7 Countries by Trial Status Clinical Trials by E7 Countries: Proportion of Portal Hypertension to Cardiovascular Clinical Trials Clinical Trials by Phase in E7 Countries Clinical Trials in E7 Countries by Trial Status Clinical Trials by Phase In Progress Trials by Phase Clinical Trials by Trial Status Clinical Trials by End Point Status Subjects Recruited Over a Period of Time Clinical Trials by Sponsor Type Prominent Sponsors Top Companies Participating in Portal Hypertension Therapeutics Clinical Trials Prominent Drugs Latest Clinical Trials News on Portal Hypertension Oct 20, 2015: Conatus Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for AASLD Annual Meeting Clinical Trial Profile Snapshots Appendix Abbreviations Definitions Research Methodology Secondary Research About Us
Contact Us Disclaimer Source List of Tables Portal Hypertension Therapeutics, Global, Clinical Trials by Region, 2016- Portal Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016- Portal Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016- Portal Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016- Portal Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2016- Portal Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2016- Portal Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016- Portal Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2016- Proportion of Portal Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2016- Portal Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016- Portal Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016- Proportion of Portal Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2016- Portal Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2016- Portal Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016- Portal Hypertension Therapeutics, Global, Clinical Trials by Phase, 2016- Portal Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2016- Portal Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 Portal Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016- List of Figures Portal Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2016- Portal Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016- Portal Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016-
Portal Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016- Portal Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016- Portal Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2016- Portal Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016- Proportion of Portal Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2016- Portal Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016- Portal Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016- Proportion of Portal Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2016- Portal Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2016- Portal Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016- Portal Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2016- Portal Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2016- Portal Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 Portal Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016- Portal Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016- Portal Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016- Methodology Ordering: Order Online - http://www.researchandmarkets.com/reports/3618524/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.
Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/ Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Portal Hypertension Global Clinical Trials Review, H1, 2016 Web Address: Office Code: Product Formats Please select the product formats and quantity you require: http://www.researchandmarkets.com/reports/3618524/ SC Electronic (PDF) - Single User: Electronic (PDF) - Site License: Electronic (PDF) - Enterprisewide: Quantity USD 2500 USD 5000 USD 7500 Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an email with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number 833 130 83 Sort code 98-53-30 Swift code IBAN number Bank Address ULSBIE2D IE78ULSB98533083313083 Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World